Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PACLITAXEL for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 984 adverse event reports in the FDA FAERS database where PACLITAXEL was used for Neoplasm malignant.

Most Reported Side Effects for PACLITAXEL

Side Effect Reports % Deaths Hosp.
Neutropenia 4,553 5.9% 572 1,391
Nausea 4,521 5.9% 488 2,147
Dyspnoea 4,519 5.8% 453 2,052
Diarrhoea 4,289 5.6% 591 2,513
Off label use 4,075 5.3% 595 1,415
Anaemia 3,949 5.1% 599 1,918
Neuropathy peripheral 3,508 4.5% 404 788
Malignant neoplasm progression 3,484 4.5% 916 760
Fatigue 3,418 4.4% 500 1,568
Death 3,143 4.1% 3,137 378
Pyrexia 3,083 4.0% 352 2,331
Vomiting 3,049 3.9% 371 1,785
Disease progression 2,939 3.8% 801 554
Febrile neutropenia 2,938 3.8% 569 1,915
Thrombocytopenia 2,580 3.3% 424 939

Other Indications for PACLITAXEL

Breast cancer (10,215) Product used for unknown indication (6,156) Ovarian cancer (4,631) Non-small cell lung cancer (4,609) Triple negative breast cancer (3,863) Pancreatic carcinoma (3,386) Breast cancer metastatic (3,241) Pancreatic carcinoma metastatic (2,712) Lung neoplasm malignant (1,747) Chemotherapy (1,425)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676) SUNITINIB MALATE (646)

Related Pages

PACLITAXEL Full Profile All Neoplasm malignant Drugs PACLITAXEL Demographics PACLITAXEL Timeline